Home » Shop » hot sale » Human TIM-4 Extracellular Domain Biotinylated

Human TIM-4 Extracellular Domain Biotinylated

Original price was: $119.20.Current price is: $88.75.

Sale!
SKU: PW14836849810 Category:

Human TIM-4 Extracellular Domain Biotinylated

Catalog number: B2016781
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 20 g
Molecular Weight or Concentration: 32.7 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80C
Keywords: T Cell Immunoglobulin and Mucin Domain-containing Protein 4, T Cell Immunoglobulin Mucin Receptor 4, T Cell Membrane Protein 4, TIMD-4
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Moon B, Yang S, Kim K, Lee J, Jeong D, Park D. EphA2 Interacts with Tim-4 through Association between Its FN3 Domain and the IgV Domain of Tim-4 Cells. 2021 May 22;10(6):1290.
  • Fang XY, Xu WD, Pan HF, Leng RX, Ye DQ. Novel insights into Tim-4 function in autoimmune diseases Autoimmunity. 2015 Jun;48(4):189-95.
  • Cieniewicz B, Bhatta A, Torabi D, Baichoo P, Saxton M, Arballo A, Nguyen L, Thomas S, Kethar H, Kukutla P, Shoaga O, Yu B, Yang Z, Fate M, Oliveira E, Ning H, Corey L, Corey D. Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation Mol Ther. 2023 Jul 5;31(7):2132-2153.
  • Mesri M, Smithson G, Ghatpande A, Chapoval A, Shenoy S, Boldog F, Hackett C, Pena CE, Burgess C, Bendele A, Shimkets RA, Starling GC. Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins Int Immunol. 2006 Mar;18(3):473-84.
  • Cao W, Ryan M, Buckley D, OConnor R, Clarkson MR. Tim-4 inhibition of T-cell activation and T helper type 17 differentiation requires both the immunoglobulin V and mucin domains and occurs via the mitogen-activated protein kinase pathway Immunology. 2011 Jun;133(2):179-89.
  • Omori S, Tsugita M, Hoshikawa Y, Morita M, Ito F, Yamaguchi SI, Xie Q, Noyori O, Yamaguchi T, Takada A, Saitoh T, Toyokuni S, Akiba H, Nagata S, Kinoshita K, Nakayama M. Tim4 recognizes carbon nanotubes and mediates phagocytosis leading to granuloma formation Cell Rep. 2021 Feb 9;34(6):108734.
  • Xiao L, Fu ZR, Liu F, Zhang LD, Shi XM, Shen XY, Ni ZJ, Fu H, Li RD, Cao XT, Ding GS, Wang QX. Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells PLoS One. 2011;6(7):e21697.
  • Hishida S, Kawakami K, Fujita Y, Kato T, Takai M, Iinuma K, Nakane K, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K. Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel-resistant prostate cancer Prostate. 2021 Jun;81(9):592-602.
  • Klaas M, Dubock S, Ferguson DJP, Crocker PR. Sialoadhesin (CD169/Siglec-1) is an extended molecule that escapes inhibitory cis-interactions and synergizes with other macrophage receptors to promote phagocytosis Glycoconj J. 2023 Apr;40(2):213-223.